作者
Nicolas Mottet, Roderick CN van den Bergh, Erik Briers, Thomas Van den Broeck, Marcus G Cumberbatch, Maria De Santis, Stefano Fanti, Nicola Fossati, Giorgio Gandaglia, Silke Gillessen, Nikos Grivas, Jeremy Grummet, Ann M Henry, Theodorus H van der Kwast, Thomas B Lam, Michael Lardas, Matthew Liew, Malcolm D Mason, Lisa Moris, Daniela E Oprea-Lager, Henk G van der Poel, Olivier Rouvière, Ivo G Schoots, Derya Tilki, Thomas Wiegel, Peter-Paul M Willemse, Philip Cornford
发表日期
2021/2/1
来源
European urology
卷号
79
期号
2
页码范围
243-262
出版商
Elsevier
简介
Objective
To present a summary of the 2020 version of the European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Geriatric Oncology (SIOG) guidelines on screening, diagnosis, and local treatment of clinically localised prostate cancer (PCa).
Evidence acquisition
The panel performed a literature review of new data, covering the time frame between 2016 and 2020. The guidelines were updated and a strength rating for each recommendation was added based on a systematic review of the evidence.
Evidence synthesis
A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50 yr of age and based on individualised life expectancy. Risk-adapted screening should be offered to men at increased risk …
引用总数
学术搜索中的文章
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021